RIDDLE&CODE
2.11.2021 10:37:13 CET | Business Wire | Press release
Drive&Stake , a decentralised, scalable end-to-end solution for the creation of automated mobility data marketplaces, promotes industry-wide data exchange and enables participants within the mobility ecosystem to obtain extensive insights through real-time data analytics.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211102005028/en/
Over the past decades, the traditional idea of everyone possessing their own car as the primary means of mobility has shifted towards more interconnected ride-sharing, car-sharing and autonomous (self-driving) vehicles. As a result, vehicles have become mobile hubs of data, generating and processing vast volumes of information. The generated data has the potential to become a key driver for the implementation of disruptive, data-driven business models and services.
However, the current infrastructure has limited communication with third-party frameworks, leaving data untapped and locked in centralised silos. As a consequence, original equipment manufacturers (OEMs) face a trade-off between opening up access to their data and retaining profits from exclusive control over it. Service providers, such as insurance or fleet management companies, are dependent on third-party analytics processes, while drivers have no control over produced data and its potential use.
Drive&Stake addresses these obstacles and empowers all participants in the mobility ecosystem to share, access and benefit from vehicle-generated data.
Service providers can reach a broader customer base, deliver enhanced customer experience, perform real-time settlement of liabilities and develop new products and features. OEMs can improve business processes and access consumer data in a transparent, auditable way, while drivers—in addition to more services at a lower cost—can enjoy a personalised customer experience and collect reward tokens for staking, consuming third-party services, swapping or exchanging for fiat currencies.
RIDDLE&CODE, the leading European blockchain interface company, is powering Drive&Stake with a flexible hardware stack and software-driven approach that unlocks data in a secure, confidential manner and tokenizes the produced data by pegging it to real-life objects. Ocean Protocol allows the exchange and monetisation of data and data-based services, overcoming the trade-off between the benefits of using private data and the risks of exposing it. Experts from EFS Consulting are transforming data into tangible use cases in close collaboration with vehicle manufacturers, mobility service providers, and insurance and energy corporations, while ELOOP has already deployed a successful use case, recording CO2 savings and mileage of electric vehicles.
“RIDDLE&CODE has built Confidential PID that enables the secure extraction of vehicle-generated data and controls how this data will be accessed and utilised,” said Thomas Fürstner, founder and CTO of RIDDLE&CODE. “This novel approach comes as a result of our extensive development efforts for other industries like fintech and energy, where RIDDLE&CODE successfully implements various encryption and trusted computing technologies,” he added.
“Curiosity for novel technologies is in the very DNA of EFS Consulting. We are delighted to channel this curiosity together with our partner RIDDLE&CODE,” said Christian Schaupp, Managing Director of EFS Consulting. “Drive&Stake is a project that reinvents the connected vehicle experience, and we are proud to be part of it. Together with RIDDLE&CODE and other industry-leading partners, we are creating new decentralised business models and services based on tokenized mobility data.”
“RIDDLE&CODE is a blockchain pioneer. They've been at the forefront of using trusted and verifiable IoT devices integrated with blockchains,” said Bruce Pon, CEO of Ocean Protocol. “Drive&Stake data will be a valuable addition to the Ocean Market and we’re very excited to create a new data economy together.”
“As a company committed to taking the sharing economy to the next level, ELOOP is delighted to be part of Drive&Stake. Today, we are deploying a first use case, recording CO2 savings and mileage of electric vehicles, and are keen to test and develop further use cases within the Drive&Stake ecosystem,” said Leroy Hofer, CEO at ELOOP.
Drive&Stake supports a variety of use cases, including pay-as-you-drive, networked parking for car-sharing, incentivised mobility patterns, sustainable EV battery and supply-chain traceability. Further use cases can be developed and implemented.
Businesses interested in exploring disrupting mobility solutions and gaining value from vehicle-generated data can contact RIDDLE&CODE for more information about joining Drive&Stake.
About RIDDLE&CODE
RIDDLE&CODE is Europe’s leading company for blockchain interface solutions. The company develops hardware and software stacks that combine the security of smart cards with blockchain and the Internet of Things (IoT). Together with its tier-one clients and partners, which include Daimler, BMW, Wien Energie and leading Dutch crypto exchange LiteBit, RIDDLE&CODE brings new business models to the fintech, energy, mobility and materials industries.
More information: www.riddleandcode.com
About EFS Consulting
EFS Consulting was established based on the idea of creating modular platform strategies within the automotive industry. Today, the consultancy company with offices in Vienna and Shanghai has expanded beyond the automotive sector with fields of competencies covering all aspects of a technological product life cycle. EFS is dedicated to empowering clients on a global scale to deliver better products, production and market solutions.
More information: www.efs.consulting
About ELOOP
ELOOP is a Vienna-based car-sharing startup with a focus on green mobility solutions and environmental protection. The company has the vision to change the way people get around in urban areas and take the sharing economy to the next level. With the power of blockchain, ELOOP has tokenized the revenue of its Tesla fleet and shares it with all ELOOP ONE token holders. The fleet of ELOOP consists purely of Tesla electric vehicles.
More information: eloop.at/en
About Ocean Protocol
Ocean Protocol is an on-ramp for data services into crypto ecosystems, using datatokens. Each datatoken is a fungible ERC20 token to access a given data service. Ocean smart contracts, Ocean libraries and Ocean-powered front ends make it easy to publish data services (deploy and mint datatokens) and consume data services (spend datatokens). Therefore, Ocean provides decentralised access control. The Ocean Protocol Foundation has allocated 20 million Ocean tokens for funding initiatives, including the Data Economy Challenge.
More information: oceanprotocol.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20211102005028/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
LTM Launches BlueVerse™ for iRun to Outcreate Managed Services in the Agentic AI Era15.6.2026 08:10:00 CEST | Press release
AI-native operations model enables enterprises to move from reactive service delivery to intelligent, outcome-driven managed services LTM, the Business Creativity partner to the world’s largest enterprises, today announced the launch of BlueVerse™ for iRun, an AI-native managed services model designed to transform traditional IT operations into a resilient, intelligent, and outcome-driven operating model. As enterprise environments grow more complex—spanning hybrid cloud, SaaS, and AI-driven ecosystems—traditional managed services models are increasingly constrained by siloed teams, static processes, and effort-led scaling. BlueVerse for iRun addresses this shift by moving beyond headcount-based delivery to a platform-led approach powered by agentic AI, knowledge convergence, and process-as-code. Built on the BlueVerse ecosystem, iRun creates a unified intelligence layer that brings together enterprise data, telemetry, workflows, and operational context—enabling AI to reason across sys
Azafaros to Present at BIO International Convention 202615.6.2026 07:00:00 CEST | Press release
Azafaros, a private company building a portfolio to become a leader in lysosomal storage disorders (LSDs), focused on addressing neurological symptoms, today announced that it will present at the 2026 BIO International Convention taking place in San Diego, USA, from June 22-25. The company’s presentation is scheduled for Monday, June 22 at 4:30 PM in Theater 4. The presentation will highlight Azafaros’ progress in developing nizubaglustat, its lead investigational compound for the treatment of rare lysosomal storage disorders with neurological involvement, including GM1 and GM2 gangliosidoses (GM1/GM2) and Niemann-Pick type C disease (NPC). Nizubaglustat is currently in two Phase 3 registrational studies (NAVIGATE) treating patients with GM1/GM2 and NPC and expects to report topline data from the studies in 2028. “BIO provides an important opportunity to update our progress as we continue advancing nizubaglustat through late-stage clinical development,” said Stefano Portolano, CEO at A
Teledyne FLIR Defense Launches Black Recon™ Autonomous Micro-Drone15.6.2026 06:05:00 CEST | Press release
Autonomous launch, recovery, and recharge from military vehicles and fixed installations; Three-drone rotation provides persistent surveillance and real-time targeting data in contested environments Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE: TDY), today announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone system that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260614388428/en/ Teledyne FLIR Defense announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. Black Recon allows crews to launch, operate, recover, and recharge up to three UAS without leaving their platform, reducing operator risk. Designed for vehicle integrati
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom